What anti-snoring mouthpieces claim to do
Anti-snoring mouthpieces, technically called mandibular advancement devices (MAD), are designed to hold your lower jaw forward while you sleep. The forward position keeps your airway open by preventing the tongue and soft tissues from collapsing backward. Manufacturers claim these devices reduce snoring, improve sleep quality, and treat mild to moderate obstructive sleep apnea (OSA).
The question “does anti snoring mouthpiece work” has a clinical answer that differs sharply from the marketing. The devices do reduce snoring in controlled trials, but the effectiveness comes with persistent side effects, high dropout rates, and a strong dependency on proper fitting and consistent use. 1
Most anti-snoring mouthpieces are either custom-fitted by a dentist or purchased as boil-and-bite models you mold at home. The clinical practice guideline from the American Academy of Sleep Medicine recommends prescription oral appliances fitted by dental professionals for adults with obstructive sleep apnea who cannot tolerate CPAP therapy or prefer an alternative treatment. 1
The devices work by physically repositioning the jaw. They do not cure the underlying anatomy that causes snoring or sleep apnea. When you stop using the device, snoring returns immediately.
Anti-snoring mouthpieces work for some people, but dropout rates are high
A 2024 randomized trial compared mandibular advancement devices to combined positional and airway therapy for snoring. The MAD group showed significant reductions in snoring frequency and loudness, but the combined therapy group performed just as well. 3 Both groups had participants who abandoned treatment within the first six months.
The dropout problem is consistent across studies. A 2019 analysis of long-term adherence found that 46% of patients initially prescribed MAD therapy were no longer using the device after a median follow-up of 2.8 years. 9 Among those who did continue, objective monitoring showed actual nightly use averaged only 6.7 hours. 9
The reasons people stop using anti-snoring mouthpieces include persistent pain, excessive salivation, and dental discomfort. A 10-year follow-up study tracked patients using either MAD or CPAP and found that while both groups had similar rates of treatment continuation, the MAD users reported significantly more dental side effects over time. 8
Ready-made devices are cheaper and faster to obtain, but custom-fitted devices are not necessarily more effective. A 2017 randomized trial compared ready-made mandibular repositioning devices to custom-made appliances and found no significant difference in snoring reduction or apnea-hypopnea index (AHI) improvement between the two groups. 4 The main advantage of custom devices is better initial comfort, which may improve early adherence.
Anti-snoring mouthpieces reduce snoring in clinical trials, but dental changes are persistent and dropout rates are high enough that many people abandon them within the first year.
The most common side effects: TMJ pain, tooth movement, and excessive salivation
Temporomandibular joint (TMJ) pain is common enough during MAD therapy that one study tested whether preventive jaw-opening exercises could reduce it. Patients who performed daily jaw exercises had significantly lower pain scores than controls. 5 The fact that preventive protocols exist signals that TMJ discomfort is expected, not rare.
A 2024 randomized trial comparing MAD therapy to other OSA treatments found that 38% of MAD users reported TMJ symptoms at six-month follow-up, compared to 12% in the CPAP group and 10% in the positional therapy group. 12 The pain was persistent enough that some participants required discontinuation.
Excessive salivation, also called sialorrhea, is another frequent complaint. The mouthpiece stimulates saliva production, and many users report waking with pooled saliva or drooling on the pillow. This side effect does not diminish with continued use. No published intervention has been shown to reliably prevent it.
Tooth movement begins within the first year of use. A 2023 review of occlusal side effects found measurable changes in dental alignment after 12 months of nightly MAD use. 11 The most common changes are a reduction in overbite (the vertical overlap of front teeth) and an increase in overjet (the horizontal distance between upper and lower front teeth). These changes are not cosmetic complaints, they are objective shifts in bite alignment measured with dental casts.
Morning jaw soreness is nearly universal during the first weeks of use. Most users adapt within a month, but a subset experience persistent discomfort that does not resolve. The 2017 study on jaw exercises found that 24% of MAD users without preventive exercises reported ongoing TMJ pain at three months. 5
Long-term use causes persistent dental changes, not temporary ones
The most important finding buried in the long-term follow-up literature is this: dental and skeletal changes from anti-snoring mouthpiece use do not reverse when you stop using the device. A 2019 meta-regression analysis pooled data from studies with follow-up periods ranging from one to ten years and found progressive changes in tooth position, overjet, overbite, and mandibular plane angle. 6
The changes are dose-dependent. Patients who used MAD devices for more than five years showed greater dental displacement than those who used them for two to three years. 7 The direction of tooth movement is consistent: lower incisors tip forward (proclination), upper incisors tip backward (retroclination), overbite decreases, and overjet increases. 6
A 2022 study specifically tracking malocclusion traits during long-term OSA management found that 67% of patients using MAD for more than three years had measurable changes in their occlusion (how upper and lower teeth meet when biting). 10 The changes were significant enough that 14% of participants required orthodontic correction or modification of the device to prevent further movement. 10
These are not temporary side effects that resolve after an adjustment period. They are cumulative structural changes to the dentition and jaw position. The 2018 review by Araie and colleagues states plainly: “Dental side effects are nearly universal and should be considered an expected outcome rather than a complication.” 7
Marketing materials for anti-snoring mouthpieces rarely mention persistent dental changes. The typical language is “minor and temporary discomfort.” The evidence shows the opposite. Every long-term study that measured dental alignment found progressive, non-reversible changes. 6 7 10 11
MAD devices reduce snoring less than CPAP but with better adherence
Continuous positive airway pressure (CPAP) remains the gold standard for obstructive sleep apnea treatment. A 2016 meta-analysis of randomized trials comparing MAD to CPAP found that CPAP was more effective at reducing the apnea-hypopnea index (AHI), but MAD had better long-term adherence. 2
The effectiveness gap is not trivial. CPAP reduces AHI by an average of 25 events per hour more than MAD. 2 For patients with moderate to severe OSA (AHI greater than 15), that difference translates to fewer oxygen desaturation events, lower cardiovascular risk, and better daytime alertness.
But adherence matters. A therapy that works perfectly but sits unused in a drawer delivers zero benefit. The same meta-analysis found that patients were more likely to continue using MAD than CPAP over a 12-month period, though both had substantial dropout rates. 2
A 2026 study comparing blood pressure outcomes between MAD and CPAP found no significant difference in blood pressure reduction between the two therapies, despite CPAP’s superior AHI reduction. 13 The authors suggest that consistent nightly use of a less-effective device may produce cardiovascular benefits comparable to inconsistent use of a more-effective one.
The table below summarizes the trade-offs between MAD and CPAP based on pooled trial data:
| Factor | MAD devices | CPAP |
|---|---|---|
| AHI reduction | Moderate (8 to 12 events/hour) | High (20 to 30 events/hour) |
| Snoring reduction | Significant but variable | Near-complete elimination |
| Common side effects | TMJ pain, tooth movement, salivation | Mask discomfort, nasal congestion, skin irritation |
| Long-term adherence | 54% still using at 2.8 years | 40 to 50% still using at 2 years |
| Persistent structural changes | Progressive dental/skeletal changes | None |
| Recommended for | Mild to moderate OSA, CPAP-intolerant | All OSA severities, first-line therapy |
MAD vs CPAP comparison based on pooled randomized trial data
The choice between MAD and CPAP is not purely clinical. Patient preference, lifestyle, and tolerance for different side effect profiles all matter. A 2015 study found that MAD was effective in reducing AHI for patients with mild to moderate OSA, but it was not superior to CPAP even in that subgroup. 16 The guideline recommendation is clear: MAD is an alternative for patients who cannot tolerate CPAP or who prefer it after informed discussion of the trade-offs. 1
When anti-snoring mouthpieces work and when they don’t
Does snoring mouthpiece work for everyone? No. Effectiveness depends on the severity of obstructive sleep apnea, the anatomy of the airway, and the amount of mandibular advancement the device provides. A 2019 study on optimal forward movement found that maximal comfortable protrusion (the farthest forward position you can tolerate) produced the greatest AHI reduction, but it also caused the most side effects. 14
MAD therapy works best for patients with mild to moderate OSA (AHI between 5 and 30 events per hour), retrognathia (a recessed lower jaw), and positional snoring (worse when sleeping on the back). It works poorly for patients with severe OSA (AHI greater than 30), large tonsils, or significant nasal obstruction. 1
A 2022 comparison of non-surgical OSA treatments found that MAD reduced AHI more than positional therapy alone but less than weight loss combined with MAD. 15 The study reinforces that MAD is not a standalone solution for everyone. It works best as part of a multi-pronged approach that includes weight management, positional training, and avoidance of alcohol before bed.
Custom titration (gradual adjustment of the forward position) improves outcomes. Devices that allow incremental advancement in 1 mm steps let patients find the balance between effectiveness and comfort. Starting at maximal protrusion causes high early dropout due to pain. 14
Anti-snoring mouthpiece problems that predict failure include:
- Inability to breathe through the nose (the device holds the jaw forward, which makes mouth breathing harder)
- Severe TMJ dysfunction or arthritis (the device applies sustained force to the joint)
- Fewer than 10 healthy teeth in each arch (the device anchors to the teeth)
- Active periodontal disease (the device can accelerate tooth loosening)
Is anti-snoring mouthpiece safe for long-term use? It depends on how you define safe. The devices do not cause life-threatening complications, but they do cause progressive dental changes that are not reversible. 6 7 Patients need to weigh the benefit of reduced snoring and improved sleep against the certainty of altered tooth position over time.
If you are considering an anti-snoring mouthpiece, ask your dentist to assess your bite alignment at baseline and then every 12 months. Early detection of tooth movement allows for device adjustment or discontinuation before the changes become severe. Do not rely on over-the-counter devices without professional monitoring if you plan to use one nightly for more than a year.
The evidence-based answer to “does anti snoring mouthpiece work” is qualified: yes, for some people, in the short to medium term, with trade-offs. The devices reduce snoring and AHI in controlled trials. They also cause persistent dental changes, frequent TMJ pain, and dropout rates high enough that nearly half of users stop within three years. The marketing simplifies the decision. The clinical literature complicates it.
Where to buy
If you decide to try an anti-snoring mouthpiece after reviewing the evidence, both custom-fitted and boil-and-bite devices are available. The 2017 randomized trial found no significant difference in snoring reduction between ready-made and custom devices, though custom fitting may improve initial comfort. 4
SnoreRX (Adjustable mandibular advancement device with micro-adjustment in 1 mm increments. Boil-and-bite fitting. $60.). Where to buy →
SnoreRX is an adjustable boil-and-bite device that allows incremental forward positioning. The ability to titrate forward movement in 1 mm steps matches the clinical recommendation for gradual advancement to balance effectiveness and side effects. 14 You mold it at home by boiling and biting, which is less precise than a dentist-fitted device but costs a fraction of the $800 to $2,000 for custom fabrication.
The device does not eliminate the risk of dental changes or TMJ pain. No over-the-counter mouthpiece has been shown to prevent the progressive tooth movement documented in long-term studies. 6 7 If you use any MAD device nightly, plan for annual dental monitoring to track alignment changes.
We are compensated when you buy through this link. This is our only revenue source. We do not test products in-house, we synthesize published evidence. Not affiliated with or endorsed by any cited research institution.
Sources
- Ramar K, et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy. J Clin Sleep Med, 2015. J Clin Sleep Med, 2015 PubMed
- Sharples LD, et al. Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea. Sleep Med Rev, 2016. Sleep Med Rev, 2016 PubMed
- Ioerger P, et al. Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg, 2024. JAMA Otolaryngol Head Neck Surg, 2024 PubMed
- Johal A, et al. Ready-Made Versus Custom-Made Mandibular Repositioning Devices in Sleep Apnea: A Randomized Clinical Trial. J Clin Sleep Med, 2017. J Clin Sleep Med, 2017 PubMed
- Ishiyama H, et al. Effect of jaw-opening exercise on prevention of temporomandibular disorders pain associated with oral appliance therapy. J Prosthodont Res, 2017. J Prosthodont Res, 2017 PubMed
- Bartolucci ML, et al. Dental and skeletal long-term side effects of mandibular advancement devices in obstructive sleep apnea patients: a systematic review with meta-regression analysis. Eur J Orthod, 2019. Eur J Orthod, 2019 PubMed
- Araie T, et al. Dental and skeletal changes associated with long-term oral appliance use for obstructive sleep apnea. Sleep Med Rev, 2018. Sleep Med Rev, 2018 PubMed
- Uniken Venema JAM, et al. Long-term obstructive sleep apnea therapy: a 10-year follow-up of mandibular advancement device and continuous positive airway pressure. J Clin Sleep Med, 2020. J Clin Sleep Med, 2020 PubMed
- de Vries GE, et al. Long-Term Objective Adherence to Mandibular Advancement Device Therapy Versus Continuous Positive Airway Pressure. J Clin Sleep Med, 2019. J Clin Sleep Med, 2019 PubMed
- Karadeniz C, et al. Oral appliance-generated malocclusion traits during the long-term management of obstructive sleep apnea in adults. Angle Orthod, 2022. Angle Orthod, 2022 PubMed
- Rana A, et al. The Occlusal Side Effects of Mandibular Advancement Device Therapy in Adult Sleep Apnea Patients. Cureus, 2023. Cureus, 2023 PubMed
- Attia AAMM, et al. Effects of different treatments for obstructive sleep apnea on temporomandibular joint: a randomized clinical trial. BMC Oral Health, 2024. BMC Oral Health, 2024 PubMed
- Cheng T, et al. Effects of mandibular advancement devices vs. CPAP on blood pressure in obstructive sleep apnea. Front Neurol, 2026. Front Neurol, 2026 PubMed
- Sakamoto Y, et al. The Most Effective Amount of Forward Movement for Oral Appliances for Obstructive Sleep Apnea. Int J Environ Res Public Health, 2019. Int J Environ Res Public Health, 2019 PubMed
- Vimal J, et al. To compare different non-surgical treatment modalities on treatment of obstructive sleep apnea. J Indian Prosthodont Soc, 2022. J Indian Prosthodont Soc, 2022 PubMed
- Durán-Cantolla J, et al. Efficacy of mandibular advancement device in the treatment of obstructive sleep apnea syndrome. Med Oral Patol Oral Cir Bucal, 2015. Med Oral Patol Oral Cir Bucal, 2015 PubMed